These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 15340112
1. The novel antiobesic HMR1426 reduces food intake without affecting energy expenditure in rats. Ortmann S, Kampe J, Gossel M, Bickel M, Geisen K, Jähne G, Lang HJ, Klaus S. Obes Res; 2004 Aug; 12(8):1290-7. PubMed ID: 15340112 [Abstract] [Full Text] [Related]
2. Locomotion is the major determinant of sibutramine-induced increase in energy expenditure. Golozoubova V, Strauss F, Malmlöf K. Pharmacol Biochem Behav; 2006 Apr; 83(4):517-27. PubMed ID: 16647108 [Abstract] [Full Text] [Related]
3. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats. Roth JD, Trevaskis JL, Wilson J, Lei C, Athanacio J, Mack C, Kesty NC, Coffey T, Weyer C, Parkes DG. Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368 [Abstract] [Full Text] [Related]
4. Effect of isocaloric diets and sibutramine on food intake, body mass variation and serum TNF-alpha levels in rats. Trapali M, Liapi C, Perelas A, Perrea D, Stroubini T, Dontas I, Couvari E, Mavri M, Galanopoulou P. Pharmacology; 2008 Aug; 82(1):15-21. PubMed ID: 18434760 [Abstract] [Full Text] [Related]
5. S 23521 decreases food intake and body weight gain in diet-induced obese rats. Claret M, Corominola H, Canals I, Nadal B, Chavanieu A, Pfeiffer B, Renard P, Gorostiaga C, Delagrange P, Grassy G, Gomis R. Obes Res; 2004 Oct; 12(10):1596-603. PubMed ID: 15536223 [Abstract] [Full Text] [Related]
6. Regulation of body weight and carcass composition by sibutramine in rats. Strack AM, Shu J, Camacho R, Gorski JN, Murphy B, MacIntyre DE, Hickey GJ. Obes Res; 2002 Mar; 10(3):173-81. PubMed ID: 11886940 [Abstract] [Full Text] [Related]
7. Synergy of sibutramine and low-dose leptin in treatment of diet-induced obesity in rats. Boozer CN, Leibel RL, Love RJ, Cha MC, Aronne LJ. Metabolism; 2001 Aug; 50(8):889-93. PubMed ID: 11474475 [Abstract] [Full Text] [Related]
8. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures. Mack CM, Moore CX, Jodka CM, Bhavsar S, Wilson JK, Hoyt JA, Roan JL, Vu C, Laugero KD, Parkes DG, Young AA. Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527 [Abstract] [Full Text] [Related]
9. Daily oral oleoyl-estrone gavage induces a dose-dependent loss of fat in Wistar rats. del Mar Grasa M, Cabot C, Esteve M, Yubero P, Masanés RM, Blay MT, Vilà R, López-Martí J, Fernández-López JA, Remesar X, Alemany M. Obes Res; 2001 Mar; 9(3):202-9. PubMed ID: 11323446 [Abstract] [Full Text] [Related]
10. Chronic central administration of apelin-13 over 10 days increases food intake, body weight, locomotor activity and body temperature in C57BL/6 mice. Valle A, Hoggard N, Adams AC, Roca P, Speakman JR. J Neuroendocrinol; 2008 Jan; 20(1):79-84. PubMed ID: 18081555 [Abstract] [Full Text] [Related]
11. Modulation of central leptin sensitivity and energy balance in a rat model of diet-induced obesity. Fam BC, Morris MJ, Hansen MJ, Kebede M, Andrikopoulos S, Proietto J, Thorburn AW. Diabetes Obes Metab; 2007 Nov; 9(6):840-52. PubMed ID: 17924866 [Abstract] [Full Text] [Related]
12. Combined effects of oral oleoyl-estrone and limited food intake on body composition of young overweight male rats. Romero MM, Esteve M, Alemany M. Int J Obes (Lond); 2006 Jul; 30(7):1149-56. PubMed ID: 16418752 [Abstract] [Full Text] [Related]
13. Topiramate reduces energy and fat gains in lean (Fa/?) and obese (fa/fa) Zucker rats. Picard F, Deshaies Y, Lalonde J, Samson P, Richard D. Obes Res; 2000 Dec; 8(9):656-63. PubMed ID: 11225714 [Abstract] [Full Text] [Related]
14. Analysis of the anorectic efficacy of HMR1426 in rodents and its effects on gastric emptying in rats. Bickel M, Gossel M, Geisen K, Jaehne G, Lang HJ, Rosenburg R, Sandow J. Int J Obes Relat Metab Disord; 2004 Feb; 28(2):211-21. PubMed ID: 14663491 [Abstract] [Full Text] [Related]
15. Influence of a selective histamine H3 receptor antagonist on hypothalamic neural activity, food intake and body weight. Malmlöf K, Zaragoza F, Golozoubova V, Refsgaard HH, Cremers T, Raun K, Wulff BS, Johansen PB, Westerink B, Rimvall K. Int J Obes (Lond); 2005 Dec; 29(12):1402-12. PubMed ID: 16151415 [Abstract] [Full Text] [Related]
16. Comparative effects of the antipsychotics sulpiride and risperidone in female rats on energy balance, body composition, fat morphology and macronutrient selection. Baptista T, de Baptista EA, Lalonde J, Plamondon J, Kin NM, Beaulieu S, Joober R, Richard D. Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1305-11. PubMed ID: 15588757 [Abstract] [Full Text] [Related]
17. Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats. Hayashi A, Sonoda R, Kimura Y, Takasu T, Suzuki M, Sasamata M, Miyata K. Brain Res; 2004 Jun 18; 1011(2):221-7. PubMed ID: 15157808 [Abstract] [Full Text] [Related]
18. The effect of ziprasidone on body weight and energy expenditure in female rats. Park S, Kim MS, Namkoong C, Park MH, Hong JP. Metabolism; 2012 Jun 18; 61(6):787-93. PubMed ID: 22209671 [Abstract] [Full Text] [Related]
19. Effects of a novel Y5 antagonist in obese mice: combination with food restriction or sibutramine. Mashiko S, Ishihara A, Iwaasa H, Moriya R, Kitazawa H, Mitobe Y, Ito J, Gomori A, Matsushita H, Takahashi T, MacNeil DJ, Van der Ploeg LH, Fukami T, Kanatani A. Obesity (Silver Spring); 2008 Jul 18; 16(7):1510-5. PubMed ID: 18421274 [Abstract] [Full Text] [Related]
20. Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats. Tallett AJ, Blundell JE, Rodgers RJ. Behav Brain Res; 2009 Mar 17; 198(2):359-65. PubMed ID: 19061919 [Abstract] [Full Text] [Related] Page: [Next] [New Search]